Alignment Healthcare (NASDAQ:ALHC) Trading Down 7.5% – Here’s Why

Posted by Brenda Bartman on Jun 1st, 2026

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report)’s share price dropped 7.5% during mid-day trading on Monday . The company traded as low as $14.18 and last traded at $14.1650. Approximately 2,233,812 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 3,811,681 shares. The stock had previously closed at $15.32.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of research analyst reports. Zacks Research raised Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Tuesday, April 28th. Weiss Ratings raised Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Raymond James Financial set a $22.00 price target on Alignment Healthcare in a report on Thursday, May 7th. Wall Street Zen raised Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Wolfe Research initiated coverage on Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 price target for the company. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $24.30.

Check Out Our Latest Stock Report on ALHC

Alignment Healthcare Price Performance

The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 153.00, a price-to-earnings-growth ratio of 2.15 and a beta of 1.14. The company has a 50-day moving average price of $18.67 and a 200-day moving average price of $19.40. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. During the same quarter last year, the firm earned ($0.05) EPS. Alignment Healthcare’s quarterly revenue was up 33.3% compared to the same quarter last year. On average, equities research analysts expect that Alignment Healthcare, Inc. will post 0.19 EPS for the current fiscal year.

Insider Activity at Alignment Healthcare

In related news, CEO John E. Kao sold 298,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $16.89, for a total transaction of $5,033,220.00. Following the transaction, the chief executive officer owned 1,508,641 shares of the company’s stock, valued at $25,480,946.49. This trade represents a 16.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 36,749 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16. Following the transaction, the president directly owned 1,058,813 shares in the company, valued at $18,889,223.92. The trade was a 3.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,569,859 shares of company stock worth $29,433,158 in the last three months. 5.20% of the stock is owned by insiders.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the business. Allworth Financial LP grew its position in shares of Alignment Healthcare by 8.9% in the 4th quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock valued at $137,000 after purchasing an additional 566 shares during the period. State of Alaska Department of Revenue raised its stake in shares of Alignment Healthcare by 6.0% during the 4th quarter. State of Alaska Department of Revenue now owns 11,296 shares of the company’s stock worth $223,000 after purchasing an additional 636 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Alignment Healthcare by 6.3% during the 3rd quarter. Integrated Wealth Concepts LLC now owns 11,230 shares of the company’s stock worth $196,000 after purchasing an additional 665 shares in the last quarter. Parallel Advisors LLC raised its stake in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH raised its stake in Alignment Healthcare by 2.3% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 37,752 shares of the company’s stock valued at $659,000 after acquiring an additional 844 shares during the period. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.